Annual D&A:
$69.54M-$42.23M(-37.79%)Summary
- As of today, GDRX annual D&A is $69.54 million, with the most recent change of -$42.23 million (-37.79%) on December 31, 2024.
- During the last 3 years, GDRX annual D&A has risen by +$31.90 million (+84.74%).
- GDRX annual D&A is now -37.79% below its all-time high of $111.77 million, reached on December 31, 2023.
Performance
GDRX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$19.73M-$1.18M(-5.66%)Summary
- As of today, GDRX quarterly D&A is $19.73 million, with the most recent change of -$1.18 million (-5.66%) on June 30, 2025.
- Over the past year, GDRX quarterly D&A has increased by +$2.76 million (+16.29%).
- GDRX quarterly D&A is now -58.65% below its all-time high of $47.71 million, reached on December 31, 2023.
Performance
GDRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$77.27M+$2.76M(+3.71%)Summary
- As of today, GDRX TTM D&A is $77.27 million, with the most recent change of +$2.76 million (+3.71%) on June 30, 2025.
- Over the past year, GDRX TTM D&A has dropped by -$34.32 million (-30.75%).
- GDRX TTM D&A is now -30.87% below its all-time high of $111.77 million, reached on December 31, 2023.
Performance
GDRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GDRX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -37.8% | +16.3% | -30.8% |
| 3Y3 Years | +84.7% | +39.9% | +59.9% |
| 5Y5 Years | +342.3% | +336.4% | +407.5% |
GDRX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -37.8% | +84.7% | -58.6% | +33.7% | -30.9% | +47.9% |
| 5Y | 5-Year | -37.8% | +342.3% | -58.6% | +261.9% | -30.9% | +407.5% |
| All-Time | All-Time | -37.8% | +609.1% | -58.6% | +354.1% | -30.9% | +1678.4% |
GDRX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $19.73M(-5.7%) | $77.27M(+3.7%) |
| Mar 2025 | - | $20.91M(+9.5%) | $74.51M(+7.1%) |
| Dec 2024 | $69.54M(-37.8%) | $19.10M(+8.9%) | $69.54M(-29.2%) |
| Sep 2024 | - | $17.54M(+3.4%) | $98.15M(-12.0%) |
| Jun 2024 | - | $16.96M(+6.4%) | $111.59M(-0.1%) |
| Mar 2024 | - | $15.94M(-66.6%) | $111.73M(-0.0%) |
| Dec 2023 | $111.77M(+94.3%) | $47.71M(+54.1%) | $111.77M(+38.6%) |
| Sep 2023 | - | $30.97M(+81.0%) | $80.63M(+25.2%) |
| Jun 2023 | - | $17.11M(+7.1%) | $64.42M(+4.9%) |
| Mar 2023 | - | $15.98M(-3.5%) | $61.41M(+6.7%) |
| Dec 2022 | $57.53M | $16.57M(+12.3%) | $57.53M(+10.1%) |
| Sep 2022 | - | $14.76M(+4.7%) | $52.26M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $14.10M(+16.5%) | $48.32M(+11.1%) |
| Mar 2022 | - | $12.10M(+7.1%) | $43.51M(+15.6%) |
| Dec 2021 | $37.64M(+64.3%) | $11.30M(+4.4%) | $37.64M(+18.4%) |
| Sep 2021 | - | $10.82M(+16.5%) | $31.79M(+16.3%) |
| Jun 2021 | - | $9.29M(+49.0%) | $27.33M(+21.1%) |
| Mar 2021 | - | $6.23M(+14.3%) | $22.56M(+9.1%) |
| Dec 2020 | $22.91M(+45.7%) | $5.45M(-14.3%) | $20.68M(+35.8%) |
| Sep 2020 | - | $6.36M(+40.7%) | $15.22M(+71.7%) |
| Jun 2020 | - | $4.52M(+4.1%) | $8.87M(+104.1%) |
| Mar 2020 | - | $4.34M | $4.34M |
| Dec 2019 | $15.72M(+60.3%) | - | - |
| Dec 2018 | $9.81M | - | - |
FAQ
- What is GoodRx Holdings, Inc. annual D&A?
- What is the all-time high annual D&A for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. annual D&A year-on-year change?
- What is GoodRx Holdings, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. quarterly D&A year-on-year change?
- What is GoodRx Holdings, Inc. TTM D&A?
- What is the all-time high TTM D&A for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. TTM D&A year-on-year change?
What is GoodRx Holdings, Inc. annual D&A?
The current annual D&A of GDRX is $69.54M
What is the all-time high annual D&A for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high annual D&A is $111.77M
What is GoodRx Holdings, Inc. annual D&A year-on-year change?
Over the past year, GDRX annual D&A has changed by -$42.23M (-37.79%)
What is GoodRx Holdings, Inc. quarterly D&A?
The current quarterly D&A of GDRX is $19.73M
What is the all-time high quarterly D&A for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high quarterly D&A is $47.71M
What is GoodRx Holdings, Inc. quarterly D&A year-on-year change?
Over the past year, GDRX quarterly D&A has changed by +$2.76M (+16.29%)
What is GoodRx Holdings, Inc. TTM D&A?
The current TTM D&A of GDRX is $77.27M
What is the all-time high TTM D&A for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high TTM D&A is $111.77M
What is GoodRx Holdings, Inc. TTM D&A year-on-year change?
Over the past year, GDRX TTM D&A has changed by -$34.32M (-30.75%)